Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD)

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 6062-6071

  Scott, Jeremy A ^a   Duongh, Mylinh ^b   Young, Aaron W ^c   Subbarao, Padmaja ^d   Gauvreau, Gail M ^b   Grasemann, Hartmut ^d  

^a LAKEHEAD UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Airway obstruction; Arginase; Arginine metabolism; Asymmetric dimethylarginine; L ornithine; Nitric oxide; Pulmonary function

Indexed keywords

ARGINASE; CITRULLINE; N (G), N (G) DIMETHYLARGININE; ORNITHINE; ORNITHINE DECARBOXYLASE; ORNITHINE OXOACID AMINOTRANSFERASE; UNCLASSIFIED DRUG; ARGININE; N,N-DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LIQUID CHROMATOGRAPHY; LUNG FUNCTION; MALE; MASS SPECTROMETRY; MIDDLE AGED; SPUTUM ANALYSIS; AGED; ANALOGS AND DERIVATIVES; ENZYMOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPUTUM; TANDEM MASS SPECTROMETRY;

AGED; ARGINASE; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; TANDEM MASS SPECTROMETRY;

EID: 84898669908     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15046062     Document Type: Article

References (38)

1. North, M.L.; Scott, J.A. L-Arginine metabolism in the lung: Reciprocal regulation of the NOS and arginase pathways. Open Nitric Oxide J. 2011, 3 (Suppl. 1-M7), 48-54.
2. Maarsingh, H.; Pera, T.; Meurs, H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch. Pharmacol. 2008, 378, 171-184.
3. Grasemann, H.; Al-Saleh, S.; Scott, J.A.; Shehnaz, D.; Mehl, A.; Amin, R.; Rafii, M.; Pencharz, P.; Belik, J.; Ratjen, F. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2011, 183, 1363-1368.
4. Scott, J.A.; North, M.L.; Rafii, M.; Huang, H.; Pencharz, P.; Subbarao, P.; Belik, J.; Grasemann, H. Asymmetric dimethylarginine is increased in asthma. Am. J. Respir. Crit. Care Med. 2011, 184, 779-785.
5. Scott, J.A.; Grasemann, H. Asymmetric dimethylarginine: A disease marker for asthma? Chest 2013, 144, 367-368.
6. Grasemann, H.; Schwiertz, R.; Matthiesen, S.; Racke, K.; Ratjen, F. Increased arginase activity in cystic fibrosis airways. Am. J. Respir. Crit. Care Med. 2005, 172, 1523-1528.
7. North, M.L.; Khanna, N.; Marsden, P.A.; Grasemann, H.; Scott, J.A. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296, L911-L920.
8. Zimmermann, N.; King, N.E.; Laporte, J.; Yang, M.; Mishra, A.; Pope, S.M.; Muntel, E.E.; Witte, D.P.; Pegg, A.A.; Foster, P.S. et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J. Clin. Investig. 2003, 111, 1863-1874.
9. Zimmermann, N.; Rothenberg, M.E. The arginine-arginase balance in asthma and lung inflammation. Eur. J. Pharmacol. 2006, 533, 253-262.
10. Gaston, B.; Drazen, J.M.; Loscalzo, J.; Stamler, J.S. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 1994, 149, 538-551.
11. Morris, C.R. Arginine and asthma. Nestle Nutr. Inst. Workshop Ser. 2013, 77, 1-15.
12. Meurs, H.; McKay, S.; Maarsingh, H.; Hamer, M.A.; Macic, L.; Molendijk, N.; Zaagsma, J. Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br. J. Pharmacol. 2002, 136, 391-398.
13. Meurs, H.; Maarsingh, H.; Zaagsma, J. Arginase and asthma: Novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol. Sci. 2003, 24, 450-455.
14. North, M.L.; Meurs, H.; Zaagsma, J.; Scott, J.A.; Maarsingh, H. Arginase in asthma-Recent developments in animal and human studies. Open Nitric Oxide J. 2010, 2, 20-36.
15. Grasemann, H.; Shehnaz, D.; Enomoto, M.; Leadley, M.; Belik, J.; Ratjen, F. L-ornithine derived polyamines in cystic fibrosis airways. PLoS One 2012, 7, e46618.
16. North, M.L.; Grasemann, H.; Khanna, N.; Inman, M.D.; Gauvreau, G.M.; Scott, J.A. Increased ornithine-derived polyamines cause airway hyperresponsiveness in a mouse model of asthma. Am. J. Respir. Cell. Mol. Biol. 2013, 48, 694-702.
17. Tanaka, H.; Masuda, T.; Tokuoka, S.; Komai, M.; Nagao, K.; Takahashi, Y.; Nagai, H. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm. Res. 2001, 50, 616-624.
18. Holguin, F.; Comhair, S.A.; Hazen, S.L.; Powers, R.W.; Khatri, S.S.; Bleecker, E.R.; Busse, W.W.; Calhoun, W.J.; Castro, M.; Fitzpatrick, A.M. et al. An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. Am. J. Respir. Crit. Care Med. 2013, 187, 153-159.
19. Lara, A.; Khatri, S.B.; Wang, Z.; Comhair, S.A.; Xu, W.; Dweik, R.A.; Bodine, M.; Levison, B.S.; Hammel, J.; Bleecker, E. et al. Alterations of the arginine metabolome in asthma. Am. J. Respir. Crit. Care Med. 2008, 178, 673-681.
20. Vallance, P.; Leone, A.; Calver, A.; Collier, J.; Moncada, S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992, 339, 572-575.
21. Schwedhelm, E.; Boger, R.H. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat. Rev. Nephrol. 2011, 7, 275-285.
22. Kurz, K.; Teerlink, T.; Sarcletti, M.; Weiss, G.; Zangerle, R.; Fuchs, D. Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers. Pharmacol. Res. 2009, 60, 508-514.
23. Boger, R.H.; Maas, R.; Schulze, F.; Schwedhelm, E. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk. Pharmacol. Res. 2009, 60, 481-487.
24. Vestbo, J.; Hurd, S.S.; Agusti, A.G.; Jones, P.W.; Vogelmeier, C.; Anzueto, A.; Barnes, P.J.; Fabbri, L.M.; Martinez, F.J.; Nishimura, M. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013, 187, 347-365.
25. Bergeron, C.; Boulet, L.P.; Page, N.; Laviolette, M.; Zimmermann, N.; Rothenberg, M.E.; Hamid, Q. Influence of cigarette smoke on the arginine pathway in asthmatic airways: Increased expression of arginase I. J. Allergy Clin. Immunol. 2007, 119, 391-397.
26. Tadie, J.M.; Henno, P.; Leroy, I.; Danel, C.; Naline, E.; Faisy, C.; Riquet, M.; Levy, M.; Israel-Biet, D.; Delclaux, C. Role of nitric oxide synthase/arginase balance in bronchial reactivity in patients with chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294, L489-L497.
27. Scrimini, S.; Pons, J.; Agusti, A.; Soriano, J.B.; Cosio, B.G.; Torrecilla, J.A.; Nunez, B.; Cordova, R.; Iglesias, A.; Jahn, A. et al. Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells. Respir Med. 2013, 107,1895-1903.
28. Guzman-Grenfell, A.; Nieto-Velazquez, N.; Torres-Ramos, Y.; Montoya-Estrada, A.; Ramirez-Venegas, A.; Ochoa-Cautino, L.; Flores-Trujillo, F.; Hicks, J.J. Increased platelet and erythrocyte arginase activity in chronic obstructive pulmonary disease associated with tobacco or wood smoke exposure. J. Investig. Med. 2011, 59, 587-592.
29. Hodge, S.; Matthews, G.; Mukaro, V.; Ahern, J.; Shivam, A.; Hodge, G.; Holmes, M.; Jersmann, H.; Reynolds, P.N. Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine. Am. J. Respir. Cell. Mol. Biol. 2011, 44, 673-681.
30. Pera, T.; Zuidhof, A.B.; Smit, M.; Menzen, M.H.; Klein, T.; Flik, G.; Zaagsma, J.; Meurs, H.; Maarsingh, H. Arginase inhibition prevents inflammation and remodeling in a guinea pig model of COPD. J. Pharmacol. Exp. Ther. 2014, doi:10.1124/jpet.113.210138.
31. Grasemann, H.; Tullis, E.; Ratjen, F. A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis. J. Cyst. Fibros. 2013, 12, 468-474.
32. Zakrzewicz, D.; Eickelberg, O. From arginine methylation to ADMA: A novel mechanism with therapeutic potential in chronic lung diseases. BMC Pulm. Med. 2009, doi:10.1186/1471-2466-9-5.
33. Gaston, B. The biochemistry of asthma. Biochim. Biophys. Acta 2011, 1810, 1017-1024.
34. Maarsingh, H.; Zaagsma, J.; Meurs, H. Arginine homeostasis in allergic asthma. Eur. J. Pharmacol. 2008, 585, 375-384.
35. See, K.C.; Christiani, D.C. Normal values and thresholds for the clinical interpretation of exhaled nitric oxide levels in the US general population: Results from the National Health and Nutrition Examination Survey 2007-2010. Chest 2013, 143, 107-116.
36. Dweik, R.A.; Boggs, P.B.; Erzurum, S.C.; Irvin, C.G.; Leigh, M.W.; Lundberg, J.O.; Olin, A.C.; Plummer, A.L.; Taylor, D.R. An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med. 2011, 184, 602-615.
37. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am. J. Respir. Crit. Care Med. 2005, 171, 912-930.
38. Brusasco, V.; Crapo, R.; Viegi, G. Coming together: The ATS/ERS consensus on clinical pulmonary function testing. Eur. Respir. J. 2005, 26, 1-2.